Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 14,586 | 13,711 | 13,012 | 11,735 | 11,069 |
| Operating Income | -14,586 | -13,711 | -13,012 | -11,735 | -11,069 |
| Other Income | 25 | 27 | 53 | 696 | 909 |
| Pre-tax Income | -14,561 | -13,684 | -12,959 | -11,039 | -10,160 |
| Net Income Continuous | -14,561 | -13,684 | -12,959 | -11,039 | -10,160 |
| Net Income | $-14,561 | $-13,684 | $-12,959 | $-11,039 | $-10,160 |
| EPS Basic Total Ops | -0.42 | -0.41 | -0.39 | -0.34 | 6.89 |
| EPS Basic Continuous Ops | -0.42 | -0.41 | -0.39 | -0.34 | 6.90 |
| EPS Diluted Total Ops | -0.42 | -0.41 | -0.39 | -0.34 | 6.89 |
| EPS Diluted Continuous Ops | -0.42 | -0.41 | -0.39 | -0.34 | 6.90 |
| EBITDA(a) | $-14,349 | $-13,477 | $-12,788 | $-11,542 | $-10,930 |